SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
GoodRx Holdings, Inc. (GDRX) trades at a trailing P/E of 23.6, forward P/E of 7.1. Trailing earnings yield is 4.23%, forward earnings yield 14.18%. PEG 0.21 (Peter Lynch undervalued ≤1.0). Graham Number is $1.91.
Criteria proven by this page:
- VALUE (78/100, Pass) — P/E is below market average (23.6); PEG ≤ 1.0 — Peter Lynch undervalued (0.21); analyst target implies upside (+43%); earnings yield beats bond yields (4.23%).
- Forward P/E 7.1 (down from trailing 23.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.21 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 4.23% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 14.18% as earnings recover.
- Analyst consensus target $3.19 (+43% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 57/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
78/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GDRX
Valuation Multiples
P/E (TTM)23.6
Forward P/E7.1
PEG Ratio0.21
Forward PEG0.03
P/B Ratio1.17
P/S Ratio0.91
EV/EBITDA2.8
Per Share Data
EPS (TTM)$0.09
Forward EPS (Est.)$0.32
Book Value / Share$1.81
Revenue / Share$2.34
FCF / Share$0.32
Yields & Fair Value
Earnings Yield4.23%
Forward Earnings Yield14.18%
Dividend Yield0.00%
Graham Number$1.91
SharesGrow IV$20.31 (+810.8%)
Analyst Target$3.19 (+43%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
-2,503.5 |
0.00 |
2,400.04 |
195.84 |
- |
| 2017 |
2,200.8 |
-10.31 |
-225.80 |
123.77 |
- |
| 2018 |
410.6 |
0.97 |
-15.47 |
72.06 |
7.49% |
| 2019 |
272.2 |
0.00 |
-16.53 |
46.32 |
- |
| 2020 |
-37.7 |
0.04 |
15.58 |
20.12 |
- |
| 2021 |
-530.5 |
5.62 |
16.11 |
17.97 |
- |
| 2022 |
-58.6 |
-1.76 |
2.36 |
2.51 |
- |
| 2023 |
-310.0 |
4.25 |
3.61 |
3.66 |
- |
| 2024 |
109.4 |
-0.37 |
2.48 |
2.26 |
- |
| 2025 |
31.7 |
0.31 |
1.57 |
1.21 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.02 |
$99.38M |
$-7.77M |
-7.8% |
| 2017 |
$0.02 |
$157.24M |
$8.84M |
5.6% |
| 2018 |
$0.12 |
$249.52M |
$43.79M |
17.6% |
| 2019 |
$0.11 |
$388.22M |
$66.05M |
17% |
| 2020 |
$-0.75 |
$550.7M |
$-293.62M |
-53.3% |
| 2021 |
$-0.06 |
$745.42M |
$-25.25M |
-3.4% |
| 2022 |
$-0.08 |
$766.55M |
$-32.83M |
-4.3% |
| 2023 |
$-0.02 |
$750.27M |
$-8.87M |
-1.2% |
| 2024 |
$0.04 |
$792.32M |
$16.39M |
2.1% |
| 2025 |
$0.09 |
$796.85M |
$30.44M |
3.8% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$0.32 |
$0.27 – $0.38 |
$764.76M |
$755.1M – $767.14M |
9 |
| 2027 |
$0.37 |
$0.28 – $0.43 |
$805.93M |
$784.31M – $837.89M |
8 |
| 2028 |
$0.44 |
$0.11 – $0.82 |
$866.61M |
$866.61M – $866.62M |
6 |
| 2029 |
$0.89 |
$0.86 – $0.91 |
$925.63M |
$902.33M – $945.83M |
4 |
| 2030 |
$0.00 |
$0.00 – $0.00 |
$914.8M |
$891.76M – $934.76M |
2 |
